Abstract | OBJECTIVE: METHOD: Twenty-one fetuses received magnesium sulfate 4-g intravenous bolus in mothers awaiting cesarean section for fetal distress in the labor room of the Complejo Hospitalario Metropolitano de la Caja de Seguro Social de Panamá, from March through August 1997. Fetal distress in labor was defined as the presence of repetitive late decelerations, persistent loss of baseline variability, severe variable decelerations, or bradycardia. RESULTS: Twenty-one fetuses received magnesium sulfate 4-g intravenous bolus in mothers awaiting cesarean section for fetal distress. Uterine activity ceased in seven patients, diminished in 13 patients and did not change in one. In all cases, but one, there was recovery of the FHR within 4 min; furthermore there was rose reactive of FHR in nine patients. The 1-min Apgar scores were 7 or above in 18 cases and the 5-min Apgar scores were 7 or above in 20 patients. CONCLUSIONS:
|
Authors | P Vigil-De Gracia, E Simití, Y Lora |
Journal | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
(Int J Gynaecol Obstet)
Vol. 68
Issue 1
Pg. 3-6
(Jan 2000)
ISSN: 0020-7292 [Print] United States |
PMID | 10687829
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Arrhythmia Agents
- Tocolytic Agents
- Magnesium Sulfate
|
Topics |
- Anti-Arrhythmia Agents
(pharmacology, therapeutic use)
- Female
- Fetal Distress
(drug therapy)
- Heart Rate, Fetal
(drug effects)
- Humans
- Magnesium Sulfate
(pharmacology, therapeutic use)
- Obstetric Labor, Premature
(prevention & control)
- Pregnancy
- Pregnancy Trimester, Third
- Prospective Studies
- Tocolytic Agents
(pharmacology, therapeutic use)
- Treatment Outcome
|